The Development of Peptides and Peptide-Modified Delivery Systems

Dear Colleagues,

Peptides widely exist in biological organisms, participate in and regulate the functional activities of various systems, organs, tissues, and cells in the body, and play an important role in life. Peptides have been used as drugs for nearly a century. So far, hundreds of peptide-based drugs, including peptides and their modifiers, have been approved worldwide for a range of applications in the prevention, diagnosis and treatment of diabetes, cancer, cardiovascular disease, immune regulation and other diseases. In addition, peptides also play a supporting role in drug delivery.

In recent years, the production of peptides has shown a positive trend. With the development of technology and equipment, the cost of peptide synthesis has been greatly reduced. Based on this, the combination of traditional synthesis methods and new technologies provides new opportunities for the production of more complex functional peptides and their analogs, as well as new options for the structural modification of peptides. Moreover, due to their good biocompatibility, peptides as drug carriers have attracted widespread attention. Peptides can be used as either modifiers or main components of drug carriers.

In connection with the above, this Special Issue invites the latest contributions in this broad and highly promising field. We welcome various types of submissions, including research articles, communications, and reviews, that focus on new approaches, methodologies, and perspectives toward the development of peptide-based drugs, materials and drug delivery systems for biomedical applications.

Dr. Xinke Zhang
Dr. Aijun Wang
Prof. Dr. Fengshan Wang
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.